Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 August 2005

Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience

Macaulay A C Onuigbo, Nnonyelum T C Onuigbo

Med Sci Monit 2005; 11(10): CR462-469 :: ID: 430303

Abstract

BACKGROUND: Worsening azotemia following initiation of angiotensin blockade(AB), in patients with CKD, RAS with/without precipitating factors is recognized. Small increases inserum creatinine following initiation of AB occur and must not warrant drug discontinuation. We anecdotallyhad observed improvement in CKD in patients with normal renal arteries and no precipitating factors,following termination of AB. The worldwide ESRD epidemic, coincident with increasing use of AB, promptedus to hypothesize a late-onset azotemia in such CKD patients. MATERIAL/METHODS: Over 30 months, 103 patientswith worsening azotemia, while on AB were evaluated. Ninety-seven patients with abnormal MRA and/or withprecipitating factors were excluded. In the remaining five, AB was discontinued, and GFR monitored. RESULTS:One male, four females, mean age 66.2 years. Three diabetic/hypertensives, one SLE/hypertensive, onediabetic/kidney transplant recipient. Mean stable AB, 25.2 months, (6-66 months). Mean follow up, 11.8months. One month following discontinuation of AB, GFR increased by a mean 45%. Mean serum creatininedecreased from 2.9+/-0.9 to 1.8+/-0.4 mg/dL (p=0.04). Uremic symptoms in 3, hyperkalemia in one, secondaryhyperparathyroidism in one, resolved. Two with anemia, now require less erythropoietin. CONCLUSIONS:We called this unrecognized potentially reversible late-onset worsening azotemia, occurring several monthsto years on stable AB, in CKD patients with normal renal arteries, without precipitating factors, late-onsetrenal failure from angiotensin blockade (LORFFAB). Pathophysiologically, the concept of microvascularRAS is invoked. The extent of LORFFAB, with millions of patients worldwide on AB, remains conjecturaland warrants further investigation.

Keywords: Angiotensin II Type 1 Receptor Blockers - adverse effects, Aged, 80 and over, angiotensin receptor antagonists, Angiotensin-Converting Enzyme Inhibitors - adverse effects, Blood Pressure, Creatinine - urine, Glomerular Filtration Rate, Kidney Failure, Chronic - urine, Prospective Studies, Uremia - physiopathology, Wisconsin

Add Comment 0 Comments

623 15

Editorial

01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209

0:00

In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750